Results 11 to 20 of about 30,853 (284)

Dual test gas pulmonary diffusing capacity in patients with idiopathic scoliosis 40 years after diagnosis [PDF]

Experimental Physiology
There is limited knowledge on diffusing capacity in scoliosis patients. It remains to be determined if impaired pulmonary diffusing capacity is mostly influenced by reduced alveolar–capillary membrane diffusing capacity (DM, CO), reduced pulmonary ...
Rie S. Thomsen, Milan Mohammad, Lærke C. Ragborg, Casper Dragsted, Søren Ohrt‐Nissen, Martin Gehrchen, Benny Dahl, Ronan M. G. Berg, Jann Mortensen   +8 more
doaj   +2 more sources

Lung diffusing capacity for nitric oxide in space: microgravity gas density interactions [PDF]

Frontiers in Physiology, 2023
Introduction: During manned space exploration lung health is threatened by toxic planetary dust and radiation. Thus, tests such as lung diffusing capacity (DL) are likely be used in planetary habitats to monitor lung health. During a DL maneuver the rate
Lars L. Karlsson, Alain Van Muylem, Dag Linnarsson   +2 more
doaj   +2 more sources

Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID‐19: A prospective cohort study (the SECURe study) [PDF]

Experimental Physiology
Many patients exhibit persistently reduced pulmonary diffusing capacity after coronavirus disease 2019 (COVID‐19). In this study, dual test gas diffusing capacity for carbon monoxide and nitric oxide (DL,CO,NO) metrics and their relationship to disease ...
Anna Agnes Lytzen, Thora Wesenberg Helt, Jan Christensen, Thomas Kromann Lund, Anna Kalhauge, Frederikke Falkencrone Rönsholt, Daria Podlekavera, Elisabeth Arndal, Anne‐Mette Lebech, Birgitte Hanel, Terese L. Katzenstein, Ronan M. G. Berg, Jann Mortensen   +12 more
doaj   +2 more sources

Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease. [PDF]

PLoS ONE, 2023
ObjectivesFibrotic interstitial lung disease (ILD) includes a large group of conditions that lead to scarring of the lungs. The lack of available 5-level EuroQol 5D (EQ5D) data has limited the ability to conduct economic evaluations in ILD.
Alyson W Wong, Huiying Sun, Ingrid A Cox, Jolene H Fisher, Nasreen Khalil, Kerri A Johannson, Veronica Marcoux, Deborah Assayag, Helene Manganas, Martin Kolb, Andrew J Palmer, Barbara de Graaff, E Haydn Walters, Peter Hopkins, Christopher Zappala, Nicole S Goh, Yuben Moodley, Vidya Navaratnam, Tamera J Corte, Christopher J Ryerson, Wei Zhang   +20 more
doaj   +2 more sources

Pulmonary diffusing capacity and dyspnoea following COVID-19: Insights from multicentre datasetsMendeley Data [PDF]

Data in Brief
Pulmonary complications remain a significant challenge for COVID-19 survivors, necessitating advanced diagnostic approaches for long-term assessment.
Gerald S. Zavorsky, Giovanni Barisione, Thomas Gille, Roberto W. Dal-Negro, Marta Núñez-Fernández, Leigh Seccombe, Gianluca Imeri, Fabiano Di Marco, Jann Mortensen, Elisabetta Salvioni, Piergiuseppe Agostoni, Vito Brusasco   +11 more
doaj   +2 more sources

Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing [PDF]

Therapeutic Advances in Respiratory Disease, 2023
Background: Small cell lung cancer (SCLC) is characterized by aggressive growth and poor prognosis. Although SCLC affects nearly exclusively heavy smokers and leads to frequent respiratory symptoms, the impact of pre-therapeutic lung function testing in ...
Kathrin Kahnert, Lilli Maria Lempert, Jürgen Behr, Laura Elsner, Toki Bolt, Amanda Tufman, Diego Kauffmann-Guerrero   +6 more
doaj   +2 more sources

Hospital admission for COVID-19 pneumonitis – long-term impairment in quality of life and lung function

European Clinical Respiratory Journal, 2022
Background and Aim Knowledge of long-term consequences of severe COVID-19 pneumonitis is of outmost importance. Our aim was, therefore, to assess the long-term impact on quality of life and lung function in adults hospitalized with severe COVID-19 ...
Marie Vejen, Ejvind Frausing Hansen, Bakir Nabil Ibrahim Al-Jarah, Casper Jensen, Pia Thaning, Klaus Nielsen Jeschke, Charlotte Suppli Ulrik   +6 more
doaj   +1 more source

Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion [PDF]

Jornal Brasileiro de Pneumologia, 2023
Objective: Lymphangioleiomyomatosis (LAM) is a rare, destructive disease of the lungs with a limited number of determinants of disease activity, which are a critical need for clinical trials.
Anthony J Esposito, Jewel Imani, Shikshya Shrestha, Shefali Bagwe, Anthony M Lamattina, Marina Vivero, Hilary J Goldberg, Ivan O Rosas, Elizabeth P Henske, Souheil Y El-Chemaly   +9 more
doaj   +1 more source

Alveolar-membrane diffusing capacity limits performance in Boston marathon qualifiers. [PDF]

PLoS ONE, 2012
PURPOSE: (1) to examine the relation between pulmonary diffusing capacity and marathon finishing time, and (2), to evaluate the accuracy of pulmonary diffusing capacity for nitric oxide (DLNO) in predicting marathon finishing time relative to that of ...
Kaleen M Lavin, Allison M Straub, Kathleen A Uhranowsky, James M Smoliga, Gerald S Zavorsky   +4 more
doaj   +1 more source

Hierarchical stratification of the factors related to exertional dyspnoea and exercise intolerance in male COPD patients

Annals of Medicine, 2022
Background The order and extent of interactions across the factors affecting exertional dyspnoea (ED) and exercise intolerance (EI) in patients with chronic obstructive pulmonary disease (COPD) are not clear.
Ming-Lung Chuang
doaj   +1 more source